back to top
My wish lists
Save your wish list
If you want to add more content to your wish list, simply log in. If you do not have a user account, please register for the Hanser Customer Center.

» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.
Your wish lists
If you want to use your wish list during your next visit, simply log in. If you do not have a user account, please register for the Hanser Customer Center.
» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.

« Back

Your advantages at a glance

  • One login for all Hanser portals
  • Individual home page for faster access to preferred content
  • Exclusive access to selected content
  • Personal wish lists on all portals
  • Central management of your personal information and newsletter subscriptions

Register now
Deutsch
Bookmark Bookmarked
03-06-2006

Clean From the Outset

The separate production line for medical-grade POM guarantees a high degree of purity in the final products

The separate production line for medical-grade POM guarantees a high degree of purity in the final products

Thanks to a new production line, the requirements of the pharmaceutical industry regarding POM can be met successfully. Impurities in raw materials and product are eliminated; a computer-aided quality management system assures complete documentation.

The requirements to be met by active ingredients in medications, packaging and related applications are becoming increasingly stringent. The guidelines require rethinking even in terms of production. In the current issue of Kunststoffe, Tilo Vaahs, Manager of Market Development for Industrial Applications at Ticona, reports on a new production line in Kelsterbach that is at present the only such operation in the world.

In Kelsterbach production of medical-grade POM (Hostaform MT) is separated completely from the other industrial grades. The separate production line presents considerably improved production conditions. These result in greater purity and traceability of all raw materials and additives. The walls and floors of the production areas can be cleaned easily, thus assuring a high level of cleanliness. Impurities and contamimants in the raw materials and final product are excluded, because there is no direct contact with the surroundings during the entire production process. The extruders have adequate sources of ventilation and are shielded appropriately. With these measures, the production conditions satisfy the requirements of the pharmaceutical industrial.

A high degree of purity and long-term traceability

In addition, the new production line is equipped with a computer-aided quality management system that permits monitoring of the entire production process from receipt of incoming goods through blending and compounding to warehousing and shipping.

All components are identified by a bar code, registered electronically and documented completely. These data are retained permanently in a formulation database. Regular quality control inspections are also performed during production and prior to shipment. In addition, samples are taken from each batch and analyzed – using methods commonly employed in the pharmaceutical industry, among others.

Dr.-Ing. Harald Sambale
sambale <AT> kunststoffe.de

contact
Ticona GmbH
Professor-Staudinger-Straße / Gebäude R300
DE 65451 Kelsterbach
Tel: +49 180 5842662
Fax: +49 180 2021202


Newsletter

Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?

Subscribe here

Subscribe here